-
公开(公告)号:US20210147801A1
公开(公告)日:2021-05-20
申请号:US16630098
申请日:2018-07-12
申请人: INSERM (INSTITUT NATIONAL DE LA SANTÉ ET DE LA RECHERCHE MÉDICALE) , UNIVERSITÉ DE NANTES , CENTRE HOSPITALER UNIVERSITAIRE DE NANTES
IPC分类号: C12N5/0783 , A61K35/17 , A61P37/06
摘要: A population of highly suppressive human CD8+CD45RClow/− Tregs is characterized by expressing Foxp3 and producing IFNγ, IL-10, IL-34 and TGFβ to mediate their suppressive activity. Accordingly, methods capable of increasing expansion and immunosuppressive capacity of such a population of CD8+CD45RClow/− Tregs are highly desirable for therapeutic purposes. Rapamycin has been shown to increase the expansion and immunosuppressive capacities of the population of CD8+CD45RClow/− Tregs. Accordingly, the method of increasing expansion and immunosuppressive capacity of a population of CD8+CD45RClow/− Tregs includes culturing the population of CD8+CD45RClow/− Tregs in presence of a rapamycin compound.